Probiotic Lactobacillus acidophilus enhances the immunogenicity of an oral rotavirus vaccine in gnotobiotic pigs
about
Rotaviruses: from pathogenesis to vaccinationOptions for improving effectiveness of rotavirus vaccines in developing countries.Characterization of a novel Lactobacillus species closely related to Lactobacillus johnsonii using a combination of molecular and comparative genomics methods.Porcine small intestinal epithelial cell line (IPEC-J2) of rotavirus infection as a new model for the study of innate immune responses to rotaviruses and probioticsDivergent immunomodulating effects of probiotics on T cell responses to oral attenuated human rotavirus vaccine and virulent human rotavirus infection in a neonatal gnotobiotic piglet disease model.Probiotics stimulate enterocyte migration and microbial diversity in the neonatal mouse intestine.Antiviral activity of Bifidobacterium adolescentis SPM1005-A on human papillomavirus type 16.Safety assessment of probiotics for human use.Development of γδ T cell subset responses in gnotobiotic pigs infected with human rotaviruses and colonized with probiotic lactobacilli.Lactobacilli and bifidobacteria promote immune homeostasis by modulating innate immune responses to human rotavirus in neonatal gnotobiotic pigs.Probiotic Lactobacillus rhamnosus GG enhanced Th1 cellular immunity but did not affect antibody responses in a human gut microbiota transplanted neonatal gnotobiotic pig model.Adjuvant effects of L. acidophilus LW1 on immune responses to the foot-and-mouth disease virus DNA vaccine in mice.High dose and low dose Lactobacillus acidophilus exerted differential immune modulating effects on T cell immune responses induced by an oral human rotavirus vaccine in gnotobiotic pigs.Lactobacillus acidophilus and Lactobacillus reuteri modulate cytokine responses in gnotobiotic pigs infected with human rotavirusDifferential Effects of Escherichia coli Nissle and Lactobacillus rhamnosus Strain GG on Human Rotavirus Binding, Infection, and B Cell Immunity.Probiotics, antibiotics and the immune responses to vaccines.Characterization of immune modulating functions of γδ T cell subsets in a gnotobiotic pig model of human rotavirus infectionDifferences in the Biodiversity of the Fecal Microbiota of Infants With Rotaviral Diarrhea and Healthy Infants.Lactobacilli and Bifidobacteria enhance mucosal B cell responses and differentially modulate systemic antibody responses to an oral human rotavirus vaccine in a neonatal gnotobiotic pig disease model.High Protective Efficacy of Probiotics and Rice Bran against Human Norovirus Infection and Diarrhea in Gnotobiotic Pigs.Probiotics and colostrum/milk differentially affect neonatal humoral immune responses to oral rotavirus vaccine.Comparison of probiotic lactobacilli and bifidobacteria effects, immune responses and rotavirus vaccines and infection in different host speciesPrenatally acquired vitamin A deficiency alters innate immune responses to human rotavirus in a gnotobiotic pig model.Toll-like receptor and innate cytokine responses induced by lactobacilli colonization and human rotavirus infection in gnotobiotic pigs.Lactobacillus rhamnosus GG on rotavirus-induced injury of ileal epithelium in gnotobiotic pigs.Dual functions of Lactobacillus acidophilus NCFM as protection against rotavirus diarrhea.Oral immunization with recombinant Lactobacillus acidophilus expressing the adhesin Hp0410 of Helicobacter pylori induces mucosal and systemic immune responses.New approaches in oral rotavirus vaccines.Development of a human rotavirus induced diarrhea model in Chinese mini-pigs.Pertussis and Rotavirus Vaccines - Controversies and Solutions.The Efficacy of Bifidobacterium longum BORI and Lactobacillus acidophilus AD031 Probiotic Treatment in Infants with Rotavirus Infection.Selection of a candidate probiotic strain of Pediococcus pentosaceus from the faecal microbiota of horses by in vitro testing and health claims in a mouse model of Salmonella infection.A combination of scGOS/lcFOS with Bifidobacterium breve M-16V protects suckling rats from rotavirus gastroenteritis.A phase trial of the oral Lactobacillus casei vaccine polarizes Th2 cell immunity against transmissible gastroenteritis coronavirus infection.Comparative In Vitro and In Vivo Studies of Porcine Rotavirus G9P[13] and Human Rotavirus Wa G1P[8].Differences of Rotavirus Vaccine Effectiveness by Country: Likely Causes and Contributing Factors.Decreased performance of live attenuated, oral rotavirus vaccines in low-income settings: causes and contributing factors.Development of probiotic-based immunoparticles for pulmonary immunization against Hepatitis BThe Mammalian Intestinal Microbiome: Composition, Interaction with the Immune System, Significance for Vaccine Efficacy, and Potential for Disease Therapy
P2860
Q24609374-8A8BAF1C-F973-4FBD-9C01-8082AABEACFAQ30241442-44E80F02-5F36-4757-ADB4-AA37555E9608Q33694888-D3148D01-F390-456F-9E7C-4A4C0DFBC7D6Q33905223-30C23A79-7EC0-4E1F-9C01-CC60CEC254F5Q34060471-B954185E-5036-4F90-A601-7E9B7E95DFCBQ34135460-AA822087-E1D4-4766-9D99-90B473875B2AQ34334476-0E4579D2-9173-4B4F-8B3B-FD303BC3265AQ34503589-CCECED47-E4D2-40BE-95BA-195EB57AC7EDQ34959167-A2FC30C3-63A5-4438-8184-3560374E98E2Q35009719-B9DD734C-ACCD-4AB9-8A8C-026EE5AD5CBBQ35145056-D5F13EFB-5346-4CC5-86C9-06F8397DCE0CQ35224063-C24C26F4-89C2-4EFE-8929-97FEEE145848Q35718185-3D9EBE02-B093-4C85-A81B-08FA199947CAQ35832515-8965FAF3-053D-488D-87EF-162604370338Q35901914-A24EF898-41F4-48FE-BC78-FB48B922D12BQ35923837-DA71E2C1-894B-4A80-BB11-739E9DF98356Q36004134-B14CE7BA-B190-42D8-9F7A-41C3E5A6206BQ36046182-5F556032-4254-47CE-BC1C-56EDA5C0D912Q36191577-F0AE8BA0-3235-47E1-B6DB-192E7F67AD80Q36194784-877508D9-C5CA-4295-8C51-3759874AF76AQ36711360-7C30557E-B93E-4369-AF71-4A93A8FF636AQ36757913-082AB2DA-23A8-4417-A1EE-B38C102CD1FBQ36788202-3CEAC42F-70C3-4350-B6C6-129607302D22Q37121858-E1DC8709-9E6E-4011-9D18-1CDDF097F62EQ37349175-CFE1B121-8F6A-4D2D-9A97-A4D22ABC02DBQ37537220-000BF669-FCB4-46D2-9017-789252CC5B26Q37545006-41CB82B4-EC2A-4737-8D7B-74EF8751FB0AQ38255552-4AC64EFE-EF33-4D84-844C-95950163D402Q39175760-4FA66EDD-87A6-41CB-894C-71BA4C2991CFQ39379357-450A5F9E-4508-4DB8-AD14-067F37EF280AQ40043144-8F0313F1-1834-4DE3-806B-595416310943Q40463941-48C1AB5A-739D-4F88-A3D6-FEFBFB2EF72BQ40700056-3EFAD46C-0ADA-4FAE-AF54-06C5FD55E71EQ40738737-BF694370-7FC8-4CF8-A50B-9EBC2AFFC1C2Q40952104-E260CC08-FFE0-4683-8187-57E5676112ECQ46243057-B10BC788-48BA-4F9B-A433-BD4BE4755432Q47291480-B436F660-2F2E-4292-833B-99D2418C1728Q57095060-65D1FB00-40C3-49C2-B3FF-4310A97471AFQ57922927-450C4B1F-3087-4DD4-BAD5-C3A941C20FA8
P2860
Probiotic Lactobacillus acidophilus enhances the immunogenicity of an oral rotavirus vaccine in gnotobiotic pigs
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Probiotic Lactobacillus acidop ...... us vaccine in gnotobiotic pigs
@ast
Probiotic Lactobacillus acidop ...... us vaccine in gnotobiotic pigs
@en
type
label
Probiotic Lactobacillus acidop ...... us vaccine in gnotobiotic pigs
@ast
Probiotic Lactobacillus acidop ...... us vaccine in gnotobiotic pigs
@en
prefLabel
Probiotic Lactobacillus acidop ...... us vaccine in gnotobiotic pigs
@ast
Probiotic Lactobacillus acidop ...... us vaccine in gnotobiotic pigs
@en
P2093
P2860
P1433
P1476
Probiotic Lactobacillus acidop ...... us vaccine in gnotobiotic pigs
@en
P2093
Ahmed E Yousef
Ana Gonzalez
Lijuan Yuan
Marli S P Azevedo
P2860
P304
P356
10.1016/J.VACCINE.2008.04.070
P407
P50
P577
2008-05-19T00:00:00Z